insights_auto
Miks on 0QF langenud? 5,87%?
Uurige põhjalikumaltchevron_right
0QF:ETR
Moderna Inc
165,12 €
arrow_downward
−5,87%(−10,30) 1 p
30. sept, 17:35:43 GMT +2 · EUR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse 0QF põhistatistika genereerimine…
Ava
180,86 €
Kõrge
182,00 €
Madal
163,62 €
Turu kapit.
76,88 mld
Keskm. maht
44,42 tuh
Maht
52,72 tuh
52 näd kõrgeim
184,20 €
52 näd madalaim
19,37 €
Töötajate arv
5 tuh
Ava
180,86 €
Kõrge
182,00 €
Madal
163,62 €
Turu kapit.
76,88 mld
Keskm. maht
44,42 tuh
Maht
52,72 tuh
52 näd kõrgeim
184,20 €
52 näd madalaim
19,37 €
Töötajate arv
5 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
Investor's Business Daily
·
5 tunni eest
Moderna, Merck Rally On Cancer Vaccine Promise. But Is The Multi-Billion-Dollar Hype Real?
Barron's
·
9 tunni eest
Moderna, Cerebras, Jabil, HPE, Cal-Maine, Mattel, and More Stocks That Explain Today’s Market
Barchart.com
·
9 tunni eest
This Analyst Just Downgraded Moderna Stock. Here's Why.
Investopedia
·
10 tunni eest
Moderna Stock Slumps as Citi Says It’s Time to Sell After 500% Rally This Year
Profiil
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In 2026, Time ranked Moderna as number one in their World's Most Impactful Companies list. Wikipedia
Teave üksuse Moderna Inc kohta